Humacyte (HUMAW) Short Interest Ratio & Short Volume → The Small Biotech with a BIG Cancer Solution (From Behind the Markets) (Ad) Free HUMAW Stock Alerts $0.72 +0.06 (+9.04%) (As of 03/27/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial Media Humacyte Short Interest DataCurrent Short Volume7,500 sharesPrevious Short Volume14,100 sharesChange Vs. Previous Month-46.81%Dollar Volume Sold Short$4,994.25Short Interest Ratio / Days to Cover0.5Last Record DateMarch 15, 2024Today's Trading Volume11,220 sharesAverage Trading Volume16,450 sharesToday's Volume Vs. Average68% Short Selling Humacyte ? Sign up to receive the latest short interest report for Humacyte and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatHUMAW Short Interest Over TimeHUMAW Days to Cover Over TimeHUMAW Percentage of Float Shorted Over Time Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… Humacyte Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20247,500 shares $4,994.25 -46.8%N/A0.5 $0.67 2/29/202414,100 shares $12,193.68 +729.4%N/A1 $0.86 2/15/20241,700 shares $1,143.25 +1,600.0%N/A0.1 $0.67 1/31/2024100 shares $45.75 -97.1%N/A0 $0.46 1/15/20243,400 shares $1,363.74 +1,033.3%N/A0.4 $0.40 12/31/2023300 shares $124.77 -75.0%N/A0 $0.42 Get the Latest News and Ratings for HUMAW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Humacyte and its competitors with MarketBeat's FREE daily newsletter. 12/15/20231,200 shares $567.12 +9.1%N/A0.2 $0.47 11/30/20231,100 shares $528.00 -47.6%N/A0.2 $0.48 11/15/20232,100 shares $1,134.00 -65.6%N/A0.3 $0.54 10/31/20236,100 shares $2,623.00 -43.0%N/A1 $0.43 10/15/202310,700 shares $7,276.00 -32.3%N/A2.2 $0.68 9/30/202315,800 shares $11,336.50 +192.6%N/A3.8 $0.72 9/15/20235,400 shares $4,330.80 -10.0%N/A1.3 $0.80 8/31/20236,000 shares $5,226.00 -35.5%N/A1.4 $0.87 8/15/20239,300 shares $8,872.20 -1.1%N/A1.8 $0.95 7/31/20239,400 shares $7,510.60 -16.1%N/A1.4 $0.80 7/15/202311,200 shares $8,954.40 +7.7%N/A0.9 $0.80 6/30/202310,400 shares $7,592.00 +73.3%N/A0.7 $0.73 6/15/20236,000 shares $5,400.00 -15.5%N/A0.4 $0.90 5/31/20237,100 shares $6,674.00 -39.3%N/A0.5 $0.94 5/15/202311,700 shares $10,413.00 +7.3%N/A0.9 $0.89 4/30/202310,900 shares $6,322.00 -34.3%N/A0.9 $0.58 4/15/202316,600 shares $10,225.60 +7.1%N/A2.4 $0.62 3/31/202315,500 shares $9,300.00 +42.2%N/A2.5 $0.60 3/15/202310,900 shares $7,384.75 +122.5%N/A1.1 $0.68 2/28/20234,900 shares $2,695.00 +6.5%N/A0.4 $0.55 2/15/20234,600 shares $2,847.86 -42.5%N/A0.4 $0.62 1/31/20238,000 shares $4,480.00 -27.9%N/A0.7 $0.56 1/15/202311,100 shares $6,547.89 -51.7%N/A1.1 $0.59 12/30/202223,000 shares $9,029.80 -35.2%N/A2.2 $0.39 HUMAW Short Interest - Frequently Asked Questions What is Humacyte's current short interest? Short interest is the volume of Humacyte shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 7,500 shares of HUMAW short. Learn More on Humacyte's current short interest. Which institutional investors are shorting Humacyte? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Humacyte: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Humacyte's short interest increasing or decreasing? Humacyte saw a decline in short interest in March. As of March 15th, there was short interest totaling 7,500 shares, a decline of 46.8% from the previous total of 14,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Humacyte stock? Short selling HUMAW is an investing strategy that aims to generate trading profit from Humacyte as its price is falling. HUMAW shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Humacyte? A short squeeze for Humacyte occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HUMAW, which in turn drives the price of the stock up even further. How often is Humacyte's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HUMAW, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: 180 Life Sciences Short Squeeze Alpha Tau Medical Short Squeeze Apollomics Short Squeeze Artelo Biosciences Short Squeeze BriaCell Therapeutics Short Squeeze Cardio Diagnostics Short Squeeze Carmell Short Squeeze Cassava Sciences Short Squeeze Celularity Short Squeeze Clene Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HUMAW) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings